Filing Details
- Accession Number:
- 0001213900-21-064981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-13 16:18:55
- Reporting Period:
- 2021-12-08
- Accepted Time:
- 2021-12-13 16:18:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690080 | 180 Life Sciences Corp. | ATNF | Pharmaceutical Preparations (2834) | 813832378 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1832327 | Marc Feldmann | 3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto CA 94306 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-08 | 5,536 | $3.95 | 2,759,930 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-12-09 | 50,000 | $4.07 | 2,809,930 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2021-12-08 | 25,000 | $0.00 | 25,000 | $3.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2021-12-08 | 2031-12-08 | No | 4 | A | Direct |
Footnotes
- Granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
- Represents shares of common stock issued in consideration for a net of $21,870 of compensation owed to the Reporting Person after the deduction for taxes for services rendered to the Company as a member of the Board of Directors.
- This transaction was executed in multiple trades at prices ranging from $4.05 to $4.10. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
